Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia

Heart Rhythm

Volumn 11, Issue 1, 2014, Pages 58-66

  Roses Noguer, Ferran ^a   Jarman, Julian W E ^a   Clague, Jonathan R ^a   Till, Jan ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Catecholaminergic polymorphic ventricular tachycardia; Implantable cardioverter defibrillator; Pediatric; Sudden cardiac death

Indexed keywords

ATENOLOL; BISOPROLOL; DEXPROPRANOLOL; FLECAINIDE; NADOLOL; NEBIVOLOL; PROPRANOLOL; SOTALOL; VERAPAMIL;

ADOLESCENT; ADULT; ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; ELECTROGRAPHY; FAINTNESS; FEMALE; FOLLOW UP; HEART ARREST; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA; YOUNG ADULT; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; GREAT BRITAIN; MORTALITY; PATHOPHYSIOLOGY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891705635     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.10.027     Document Type: Article

References (31)

1. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients Circulation 91 1995 1512 1519
2. C. van der Werf, A.H. Zwinderman, and A.A. Wilde Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments Europace 14 2012 175 183
3. R. Bai, C. Napolitano, R. Bloise, N. Monteforte, and S.G. Priori Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing Circ Arrhythm Electrophysiol 2 2009 6 15
4. A. Medeiros-Domingo, Z.A. Bhuiyan, and D.J. Tester et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis J Am Coll Cardiol 54 2009 2065 2074
5. M. Hayashi, I. Denjoy, and F. Extramiana et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119 2009 2426 2434
6. H. Watanabe, N. Chopra, and D. Laver et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans Nat Med 15 2009 380 383
7. C. van der Werf, P.J. Kannankeril, and F. Sacher et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia J Am Coll Cardiol 57 2011 2244 2254
8. A.A. Wilde, Z.A. Bhuiyan, and L. Crotti et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia N Engl J Med 358 2008 2024 2029
9. J. Atallah, F. Fynn-Thompson, F. Cecchin, D.J. DiBardino, E.P. Walsh, and C.I. Berul Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias Ann Thorac Surg 86 2008 1620 1625
10. C.J. Garratt, P. Elliott, and E. Behr et al. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes Europace 12 2010 1156 1175
11. U. Mohamed, M.H. Gollob, R.M. Gow, and A.D. Krahn Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia Heart Rhythm 3 2006 1486 1489
12. V. Palanca, A. Quesada, A. Trigo, and J. Jimenez [Arrhythmic storm induced by AICD discharge in a patient with catecholaminergic polymorphic ventricular tachycardia] Rev Esp Cardiol 59 2006 1079 1080
13. S. Pizzale, M.H. Gollob, R. Gow, and D.H. Birnie Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 19 2008 1319 1321
14. G.H. Bardy, W.M. Smith, and M.A. Hood et al. An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
15. J.W. Jarman, K. Lascelles, T. Wong, V. Markides, J.R. Clague, and J. Till Clinical experience of entirely subcutaneous implantable cardioverter- defibrillators in children and adults: cause for caution Eur Heart J 33 2012 1351 1359
16. E.O. Robles de Medina, R. Bernard, and P. Coumel et al. WHO/ISFC Task Force. Definition of terms related to cardiac rhythm Eur J Cardiol 8 1978 127 144
17. C. Napolitano, and S.G. Priori Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 675 678
18. R. Rosso, J.M. Kalman, and O. Rogowski et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 4 2007 1149 1154
19. H. Swan, P. Laitinen, K. Kontula, and L. Toivonen Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations J Cardiovasc Electrophysiol 16 2005 162 166
20. 2+ handling and arrhythmogenesis Circ Res 108 2011 871 883
21. C.I. Berul, G.F. Van Hare, and N.J. Kertesz et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients J Am Coll Cardiol 51 2008 1685 1691
22. I. Marai, A. Khoury, and M. Suleiman et al. Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia Am J Cardiol 110 2012 72 76
23. C.Y. Miyake, G. Webster, and R.J. Czosek et al. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate Circ Arrhythm Electrophysiol 6 2013 579 587
24. M. Cerrone, C. Napolitano, and S.G. Priori Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation Heart Rhythm 6 2009 1652 1659
25. S.G. Priori, C. Napolitano, and N. Tiso et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
26. H. Lahat, E. Pras, and T. Olender et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
27. N. Roux-Buisson, M. Cacheux, and A. Fourest-Lieuvin et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human Hum Mol Genet 21 2012 2759 2767
28. M. Nyegaard., M.T. Overgaard, and M.T. Sondergaard Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death Am J Hum Genet 91 2012 703 712
29. S. Valent, and P. Kelly Images in clinical medicine. Digoxin-induced bidirectional ventricular tachycardia N Engl J Med 336 1997 550
30. B. Lown, R. Kleiger, and J. Williams Cardioversion and digitalis drugs: changed threshold to electric shock in digitalized animals Circ Res 17 1965 519 531
31. P.B. Tabereaux, D.J. Dosdall, and R.E. Ideker Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci Heart Rhythm 6 2009 405 415